nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
|
Belhassen, Manon |
|
|
24 |
6 |
p. 867-875 |
artikel |
2 |
Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients
|
Pan, Chen-Wei |
|
|
24 |
6 |
p. 885-893 |
artikel |
3 |
Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study
|
Hansen, Tonya Moen |
|
|
24 |
6 |
p. 877-884 |
artikel |
4 |
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries
|
Li, Xiao |
|
|
24 |
6 |
p. 909-922 |
artikel |
5 |
Does competition improve hospital performance: a DEA based evaluation from the Netherlands
|
Dohmen, Peter |
|
|
24 |
6 |
p. 999-1017 |
artikel |
6 |
Do mobile hospital teams in residential aged care facilities increase health care efficiency: an evaluation of French residential care policy
|
Penneau, Anne |
|
|
24 |
6 |
p. 923-937 |
artikel |
7 |
The application of discrete choice experiments eliciting young peoples’ preferences for healthcare: a systematic literature review
|
Williams, Galina |
|
|
24 |
6 |
p. 987-998 |
artikel |
8 |
The handling of missing data in trial-based economic evaluations: should data be multiply imputed prior to longitudinal linear mixed-model analyses?
|
Ben, Ângela Jornada |
|
|
24 |
6 |
p. 951-965 |
artikel |
9 |
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK
|
Viljoen, Adie |
|
|
24 |
6 |
p. 895-907 |
artikel |
10 |
Trends and drivers of pharmaceutical expenditures from systemic anti-cancer therapy
|
Børty, Lars |
|
|
24 |
6 |
p. 853-865 |
artikel |
11 |
Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand
|
Claflin, Suzi |
|
|
24 |
6 |
p. 939-950 |
artikel |
12 |
Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks
|
Perry-Duxbury, Meg |
|
|
24 |
6 |
p. 967-986 |
artikel |